| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
National Research Corp (NRC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. NRC is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 172.0K | $3.19M | - | |
| COO | 140.5K | $2.61M | - | |
| VP | 100.0K | $1.85M | - | |
| Dir | 22.6K | $419.5K | - | |
| Dir | 22.6K | $419.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2017 | K/i/e/trust Under Agreement 3/9/09 | 10% Owner | Sell | 18,195 | $38.00 | $691,441.99 | -0.1% | |
| Oct 25, 2017 | K/i/e/trust Under Agreement 3/9/09 | 10% Owner | Sell | 2,394 | $38.00 | $90,972.00 | - | |
| Oct 20, 2017 | K/i/e/trust Under Agreement 3/9/09 | 10% Owner | Sell | 110,144 | $37.01 | $4,076,520.05 | -1.0% | |
| Jul 3, 2017 | Nunnelly John N | Director | Sale+OE | 2,785 | $27.08 | $75,430.21 | -4.6% | |
| Jun 29, 2017 | Nunnelly John N | Director | Sale+OE | 846 | $27.00 | $22,842.00 | -2.9% | |
| Jun 28, 2017 | Nunnelly John N | Director | Sale+OE | 5,059 | $27.13 | $137,241.04 | -8.1% | |
| Jun 26, 2017 | Nunnelly John N | Director | Sale+OE | 9,635 | $27.18 | $261,917.87 | -14.4% | |
| Jun 22, 2017 | Nunnelly John N | Director | Sale+OE | 209 | $27.25 | $5,695.50 | -0.7% | |
| Jun 21, 2017 | Nunnelly John N | Director | Sale+OE | 2,159 | $27.38 | $59,112.70 | -1.8% | |
| Jun 19, 2017 | Nunnelly John N | Director | Sale+OE | 11,168 | $27.53 | $307,400.79 | -16.3% |